{
    "eid": "2-s2.0-85123569546",
    "title": "Eliminating viral hepatitis in children after liver transplants: How to reach the goal by 2030",
    "cover-date": "2022-01-21",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Gastroenterology",
            "@code": "2715",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Adolescent",
        "Children",
        "Elimination",
        "Infection",
        "Liver transplantation",
        "Viral hepatitis"
    ],
    "authors": [
        "Palittiya Sintusek",
        "Kessarin Thanapirom",
        "Piyawat Komolmit",
        "Yong Poovorawan"
    ],
    "citedby-count": 1,
    "ref-count": 152,
    "ref-list": [
        "Liver Transplantation Reverses Hepatic Myelopathy in 2 Children With Hepatitis A Infection",
        "Acute hepatitis A and acquired immunity to hepatitis A virus in hepatitis B virus (HBV) carriers and in HBV- or hepatitis C virus-related chronic liver diseases in Thailand",
        "An epidemic of clamassociated hepatitis",
        "Effect of degree of acetylation on gelation of konjac glucomannan",
        "Immunization status and hospitalization for vaccine-preventable and non-vaccine-preventable infections in liver-transplanted children",
        "Declining Trend of Hepatitis A Seroepidemiology in Association with Improved Public Health and Economic Status of Thailand",
        "Recurrence of clinically significant hepatitis A following liver transplantation for fulminant hepatitis A",
        "Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients",
        "Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients",
        "Immunogenicity of hepatitis A vaccine in decompensated liver disease",
        "Hepatitis A immunisation in persons not previously exposed to hepatitis A",
        "Immunogenicity and safety of hepatitis A vaccine in children with chronic liver disease",
        "Hepatitis A antibodies in liver transplant recipients: Evidence for loss of immunity posttransplantation",
        "In-hospital post-transplant acute hepatitis A viral (HAV) infection in a liver transplant recipient who was HAV seropositive pre-transplant",
        "Hepatitis B vaccine: Efficacy in high-risk settings, a two-year study",
        "A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: Immunization of infants, children, and adolescents",
        "Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers",
        "Seroprotection after recombinant hepatitis B vaccination among newborn infants: A review",
        "Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response: A 20-year follow-up study in Thailand",
        "Hepatitis B vaccination in patients with chronic hepatitis C",
        "Immune response to hepatitis B vaccine in patients with chronic hepatitis C infection: A systematic review and meta-analysis",
        "Hepatitis B vaccine efficacy in patients with chronic liver disease by hepatitis C virus",
        "Response to hepatitis B virus vaccination in individuals with chronic hepatitis C virus infection",
        "Immunogenicity of recombinant hepatitis B virus vaccine in patients with and without chronic hepatitis C virus infection: A case-control study",
        "Double-dose hepatitis B vaccination in cirrhotic patients on a liver transplant waiting list",
        "Response to a vaccination schedule with 4 doses of 40 microg against hepatitis B virus in cirrhotic patients evaluated for liver transplantation",
        "Effect of hepatitis B vaccination in patients with chronic hepatitis C",
        "Efficacy of double dose recombinant hepatitis B vaccination in chronic hepatitis C patients, compared to standard dose vaccination",
        "Response to hepatitis B vaccination by liver transplant candidates",
        "Response to vaccination against hepatitis B virus with a schedule of four 40-\u03bcg doses in cirrhotic patients evaluated for liver transplantation: Factors associated with a response",
        "Accelerated schedule of hepatitis B vaccination in liver transplant candidates",
        "Hepatitis B vaccination in liver transplant candidates",
        "Ineffectiveness of hepatitis B vaccination in cirrhotic patients waiting for liver transplantation",
        "The role of hepatitis B vaccine challenge dose in patients with underlying health conditions",
        "Response to hepatitis B vaccination in patients with liver cirrhosis",
        "Intramuscular versus intradermal administration of anti-hepatitis B vaccine in non-cirrhotic hepatitis C patients",
        "The effect of high dose and short interval HBV vaccination in individuals with chronic hepatitis C",
        "A systematic review and meta-analysis of management options for adults who respond poorly to hepatitis B vaccination",
        "NEW IMMUNIZATION SCHEDULE EFFECTIVENESS AGAINST HEPATITIS B IN LIVER TRANSPLANTATION PATIENTS",
        "Risk factors of de novo hepatitis B virus infection in pediatric hepatitis B core antibody positive liver graft recipients under prophylactic therapy",
        "High prevalence of hepatitis B nonimmunity in vaccinated pediatric liver transplant recipients",
        "High prevalence of hepatitis B-antibody loss and a case report of de novo hepatitis B virus infection in a child after living-donor liver transplantation",
        "Active immunization to prevent de novo hepatitis B virus infection in pediatric live donor liver recipients",
        "Pharmacotherapy options for managing hepatitis B in children",
        "Prevention of de novo hepatitis B virus infection in living donor liver transplantation using hepatitis B core antibody positive donors",
        "Liver transplantation using hepatitis B core antibody-positive grafts: Review and university of Tokyo experience",
        "Prevention of hepatitis B virus infection from hepatitis B core antibodypositive donor graft using hepatitis B immune globulin and lamivudine in living donor liver transplantation",
        "Prophylactic Strategy Against De Novo Hepatitis B Virus Infection for Pediatric Recipients Who Receive Hepatitis B Core Antibody-Positive Liver Grafts",
        "Active vaccination to prevent de novo hepatitis B virus infection in liver transplantation",
        "De novo HBV Hepatitis in a Child with Liver Transplantation",
        "Immunogenicity of two accelerated hepatitis B vaccination protocols in liver transplant candidates",
        "Risk of de novo hepatitis in liver recipients from hepatitis-B core antibody-positive grafts - a systematic analysis",
        "Hepatitis B virus vaccine switch program for prevention of de novo hepatitis B virus infection in pediatric patients",
        "Clinical course of de novo hepatitis B infection after pediatric liver transplantation",
        "De novo hepatitis B virus infection developing after liver transplantation using a graft positive for hepatitis B core antibody",
        "Favourable outcome of adefovirdipivoxil treatment in acute de novo hepatitis B after liver transplantation",
        "Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: A randomised, double-blind, phase 3, noninferiority trial",
        "Long-term outcomes with oral therapy in liver transplant recipients with hepatitis B",
        "The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus",
        "Association of the S267F variant on NTCP gene and treatment response to pegylated interferon in patients with chronic hepatitis B: A multicentre study",
        "JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic Infection",
        "RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg",
        "Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Na\u00efve to Nucleos(t)ide Therapy",
        "Toll-Like Receptor Response to Hepatitis B Virus Infection and Potential of TLR Agonists as Immunomodulators for Treating Chronic Hepatitis B: An Overview",
        "Discovery of GS-9688 (Selgantolimod) as a Potent and Selective Oral Toll-Like Receptor 8 Agonist for the Treatment of Chronic Hepatitis B",
        "T-cell exhaustion in chronic hepatitis B infection: Current knowledge and clinical significance",
        "Therapeutic vaccination for chronic hepatitis B: A systematic review and meta-analysis",
        "Will we need novel combinations to cure HBV infection?",
        "Evolution and Revolution of Hepatitis C Management: From Non-A, Non-B Hepatitis Toward Global Elimination",
        "Where are the children in national hepatitis C policies?",
        "Global prevalence of hepatitis C virus in children in 2018: A modelling study",
        "Perinatal transmission of hepatitis C virus",
        "Vertical transmission of hepatitis C virus: Systematic review and meta-analysis",
        "Increased Hepatitis C Virus (HCV) Detection in Women of Childbearing Age and Potential Risk for Vertical Transmission - United States and Kentucky, 2011-2014",
        "Hepatitis C Virus Infection Among Reproductive-Aged Women and Children in the United States, 2006 to 2014",
        "Mother-to-infant transmission of hepatitis C virus: Rate of infection and assessment of viral load and IgM anti-HCV as risk factors",
        "Mother to child transmission of hepatitis C virus: Rate of infection and risk factors",
        "Mother to child transmission of hepatitis C virus: Prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. Tuscany Study Group on Hepatitis C Virus Infection",
        "Hepatitis C surveillance among youth and young adults in New York City, 2009-2013",
        "Hepatitis C virus infection among adolescents and young adults:Massachusetts, 2002-2009",
        "Prevalence and burden of HCV co-infection in people living with HIV: A global systematic review and meta-analysis",
        "Acute HCV in HIV-positive individuals - a review",
        "Long-term course of chronic hepatitis C in children: From viral clearance to end-stage liver disease",
        "Impact of hepatitis C virus infection on children and their caregivers: Quality of life, cognitive, and emotional outcomes",
        "Mother-to-child transmission of hepatitis C virus",
        "Altered natural killer cells subsets distribution in children with hepatitis C following vertical transmission",
        "Clinical features and progression of perinatally acquired hepatitis C virus infection",
        "Hepatitis C viraemia after apparent spontaneous clearance in a vertically infected child",
        "Fibrosis in chronic hepatitis C acquired in infancy: Is it only a matter of time?",
        "Thyroid function and antithyroid autoantibodies in untreated children with vertically acquired chronic hepatitis C virus infection",
        "The Canadian Network on Hepatitis C BlueprintWriting Committee andWorking Groups. Blueprint to inform Hepatitis C Elimination Efforts in Canada. 2019 91 Society for Maternal-Fetal Medicine (SMFM), Hughes BL, Page CM, Kuller JA. Hepatitis C in pregnancy: Screening, treatment, and management",
        "Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection",
        "Follow-up of transmission of hepatitis C to babies of human immunodeficiency virus-negative women: The role of breast-feeding in transmission",
        "MEDICINE. Global control of hepatitis C virus",
        "HCV core antigen is an alternative marker to HCV RNA for evaluating active HCV infection: Implications for improved diagnostic option in an era of affordable DAAs",
        "The future of viral hepatitis testing: Innovations in testing technologies and approaches",
        "Pharmacology Update for the Treatment of Hepatitis C Virus",
        "EASL recommendations on treatment of hepatitis C: Final update of the series",
        "Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection",
        "Sofosbuvir/Velpatasvir for the treatment of Hepatitis C Virus infection",
        "Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Virus: Part 1 of the DORA Study",
        "Generic sofosbuvir/ledipasvir for the treatment of genotype 4 chronic hepatitis C in Egyptian children (9-12 years) and adolescents",
        "Real-Life Experience with Ledipasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C Virus Infection with Genotypes 1 and 4 in Children Aged 12 to 17 Years-Results of the POLAC Project",
        "Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Children With Chronic HCV: Part 2 of the DORA Study",
        "Outcomes in pediatric hepatitis C transplant recipients: Analysis of the UNOS database",
        "Hepatitis C Diagnosis: Simplified Solutions, Predictive Barriers, and Future Promises",
        "Hepatitis C Virus Treatment in Patients With Chronic Kidney Disease and in Kidney Transplant Recipients",
        "The optimal timing of hepatitis C therapy in liver transplant-eligible patients: Cost-effectiveness analysis of new opportunities",
        "Cost Effectiveness of Pre- vs Post-Liver Transplant Hepatitis C Treatment With Direct-Acting Antivirals",
        "Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection",
        "Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route",
        "Hepatitis E virus and chronic hepatitis in organ-transplant recipients",
        "Emergence of autochthonous infections with hepatitis E virus of genotype 4 in Europe",
        "Prevalence of Hepatitis E Virus among Adults in South-West of Iran",
        "Sero-epidemiology of hepatitis E virus (HEV) in urban and rural children of North India",
        "Epidemiology of hepatitis E virus in the United States: Results from the Third National Health and Nutrition Examination Survey, 1988-1994",
        "Seroprevalence of hepatitis E antibodies and risk profile of HEV seropositivity in The Netherlands, 2006-2007",
        "Hepatitis E virus seroprevalence in three hyperendemic areas: Nepal, Bangladesh and southwest France",
        "Mother-to-child transmission of hepatitis E virus infection",
        "Posttransplantation hepatitis E: Transfusion-transmitted hepatitis rising from the ashes",
        "A case of transfusiontransmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route",
        "Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient",
        "Hepatitis E virus in blood components: A prevalence and transmission study in southeast England",
        "Prevalence, persistence and liver enzyme levels of HGV RNA-positive blood donors determined by large-scale screening and transmission by blood components",
        "Hepatitis E in Children: A Position Paper by the ESPGHAN Hepatology Committee",
        "Hepatitis E virus infection",
        "Chronic hepatitis E infection in children with liver transplantation",
        "Prevalence of hepatitis E virus infection in pediatric solid organ transplant recipients-a single-center experience",
        "Results of single-center screening for chronic hepatitis E in children after liver transplantation and report on successful treatment with ribavirin",
        "Paediatric liver transplanted patients and prevalence of hepatitis E virus",
        "Cirrhosis due to chronic hepatitis E infection in a child post-bone marrow transplant",
        "Ribavirin as a First Treatment Approach for Hepatitis E Virus Infection in Transplant Recipient Patients",
        "HEV study protocol : Design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural Bangladesh",
        "Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: A large-scale, randomised, double-blind placebo-controlled, phase 3 trial",
        "Long-term efficacy of a hepatitis E vaccine",
        "Chronic hepatitis E virus infection in a pediatric female liver transplant recipient",
        "Seroprevalence of Hepatitis E virus infection in children after liver transplantation: A single-center experience in France",
        "Molecular detection of hepatitis E virus (HEV) in liver biopsies after liver transplantation",
        "Detection of viral hepatitis E in clinical liver biopsies",
        "New insights into the ORF2 capsid protein, a key player of the hepatitis E virus lifecycle",
        "Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: Pangenotypic evaluation of performances",
        "Diagnosis of hepatitis E",
        "Hepatitis E virus infection in liver transplant recipients: A descriptive literature review",
        "Screening of novel drugs for inhibiting hepatitis E virus replication",
        "Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNADependent RNA Polymerase",
        "Activities of Thrombin and Factor Xa Are Essential for Replication of Hepatitis E Virus and Are Possibly Implicated in ORF1 Polyprotein Processing",
        "Zinc: A Potential Antiviral Against Hepatitis E Virus Infection?",
        "Development of new hepatitis E vaccines",
        "Prophylactic Hepatitis E Vaccine",
        "Prophylactic Hepatitis E Vaccines: Antigenic Analysis and Serological Evaluation"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Center of Excellence in Clinical Virology, Faculty of Medicine, King Chulalongkorn Memorial Hospital",
        "King Chulalongkorn Memorial Hospital",
        "National Research Council",
        "Chulalongkorn University",
        "NSTDA",
        "National Research Council of Thailand",
        "Foundation for the Promotion of Science and Technology"
    ]
}